TY - JOUR
T1 - Folate-Responsive Homocystinuria and Schizophrenia
T2 - A Defect in Methylation Due to Deficient 5,10-Methylenetetrahydrofolate Reductase Activity
AU - Freeman, John M.
AU - Finkelstein, James D.
AU - Mudd, S. Harvey
PY - 1975/3/6
Y1 - 1975/3/6
N2 - Homocystinuria and homocystinemia without hypermethioninemia, but with recurrent episodes of folate responsive schizophrenic-like behavior, was documented in a mildly retarded adolescent girl who lacked the habitus associated with cystathionine synthase deficiency. Enzymes involved in homocysteine-methionine metabolism were demonstrated to be normal. A defect in the ability to reduce N-5–10-methylenetetrahydrofolate to 5-methyltetrahydrofolate was demonstrated. Methylenetetrahydrofolate reductase was 18 per cent of control values. Methyltetrahydrofolate is used for the methylation of homocysteine to methionine, and a deficiency of this compound could explain the homocystinemia and homocystinuria. (N Engl J Med 292: 491–496, 1975), THE most frequently encountered cause of homocystinuria, an aminoaciduria described in 1962,1,2 has been deficient activity of cystathionine-β-synthase (E.C.4.2.1.22), the enzyme that catalyzes the condensation of homocysteine with serine.3 However, homocystinuria has also been described as a consequence of defects in the methylation of homocysteine to methionine4,5 and of the administration of 6-azauridine triacetate.6 The case reported below concerns a girl with a previously unrecognized cause of homocystinuria: a deficient activity of 5,10-methylenetetrahydrofolate reductase (E.C.1.1.1.68). This enzyme is necessary for the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a compound that serves as the methyl donor for the methylation of homocysteine to.
AB - Homocystinuria and homocystinemia without hypermethioninemia, but with recurrent episodes of folate responsive schizophrenic-like behavior, was documented in a mildly retarded adolescent girl who lacked the habitus associated with cystathionine synthase deficiency. Enzymes involved in homocysteine-methionine metabolism were demonstrated to be normal. A defect in the ability to reduce N-5–10-methylenetetrahydrofolate to 5-methyltetrahydrofolate was demonstrated. Methylenetetrahydrofolate reductase was 18 per cent of control values. Methyltetrahydrofolate is used for the methylation of homocysteine to methionine, and a deficiency of this compound could explain the homocystinemia and homocystinuria. (N Engl J Med 292: 491–496, 1975), THE most frequently encountered cause of homocystinuria, an aminoaciduria described in 1962,1,2 has been deficient activity of cystathionine-β-synthase (E.C.4.2.1.22), the enzyme that catalyzes the condensation of homocysteine with serine.3 However, homocystinuria has also been described as a consequence of defects in the methylation of homocysteine to methionine4,5 and of the administration of 6-azauridine triacetate.6 The case reported below concerns a girl with a previously unrecognized cause of homocystinuria: a deficient activity of 5,10-methylenetetrahydrofolate reductase (E.C.1.1.1.68). This enzyme is necessary for the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a compound that serves as the methyl donor for the methylation of homocysteine to.
UR - http://www.scopus.com/inward/record.url?scp=0016670730&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016670730&partnerID=8YFLogxK
U2 - 10.1056/NEJM197503062921001
DO - 10.1056/NEJM197503062921001
M3 - Article
C2 - 1117892
AN - SCOPUS:0016670730
SN - 0028-4793
VL - 292
SP - 491
EP - 496
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 10
ER -